The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

North America held the largest dermatitis market share, and Middle East was the fastest-growing region in 2022.

The global dermatitis market is expected to grow from $6.46 billion in 2022 to $6.89 billion in 2023 at a compound annual growth rate (CAGR) of 6.6%. The global dermatitis market size is expected to grow to $8.57 billion in 2027 at a CAGR of 5.6%.

Major Driver In The Dermatitis Market ­– Increase In Global Prevalence Of The Disease
According to the allergy asthma network 2020, around 31.6 million Americans suffer from some sort of atopic dermatitis. Atopic dermatitis affects 15-20 percent of children worldwide and 1 to 3 percent of adults.

View More On The Dermatitis Market Report 2023 – https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

Key Dermatitis Market Segments
1) By Drug Class: Corticosteroids, Emollients/Moisturizers, Antihistamines, Calcineurin Inhibitors, Antibiotics, Immunomodulators, Interleukin Inhibitors
2) By Distribution Channel: Hospital, Retail Pharmacies, Drug Stores, Online Or Mail Pharmacies
3) By Route Of Application: Topical, Oral, Injectable
4) By Application: Cancer, Blood Disorders, Chronic Diseases, Infectious Diseases

Recent Dermatitis Market Trend – Increasing Mergers And Acquisitions
The dermatitis market has seen an increase in mergers and acquisitions (M&As) for the goal of corporate expansion and visibility. M&As are playing an important part in today’s world and are expected to develop this sector in the coming years. To grow their portfolios and strengthen their market position, companies in this business are focused on collaboration and partnerships. Companies are also intentionally acquiring businesses to minimise competition and boost scalability. For example, in January 2020, Eli Lilly and corporation, a US-based pharmaceutical corporation specialising in the research, development, production, and commercialization of human pharmaceuticals, paid $1.1 billion to buy Dermira, Inc. Lebrikizumab, an innovative, investigational monoclonal antibody, has been introduced to Eli Lilly’s immunology pipeline and commercialised dermatology drugs for the treatment of moderate-to-severe atopic dermatitis in patients 12 years of age and older. Dermira, Inc. is a biopharmaceutical firm established in the United States that is a pioneer in the discovery and development of innovative medicines for dermatology patients.

Dermatitis Market Prominent Players
Major players in the dermatitis market are LEO Pharma A/S, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi S.A., Bayer HealthCare, Encore Dermatology Inc., Meda Pharmaceuticals, Allergan PLC. (Republic of Ireland) and Bristol-Myers Squibb.

Request A Sample Of The Global Dermatitis Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2413&type=smp

The Dermatitis Global Market Report 2023  provides a comprehensive overview on the dermatitis market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the dermatitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Dermatitis refers to the treatment of skin inflammation, which is distinguished by itchy rashes on swollen and reddish skin on the body’s outer layer. It is a broad word for a common type of skin irritation.

View More Related Reports –
Atopic Dermatitis Global Market Report 2023
Pruritus Therapeutic Global Market Report 2023
Dermatology Medical Lasers Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model